SCHEMBL12049853

SCHEMBL12049853

B[C@@H]1O[C@H](C=O)[C@@H](O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12769536 1.00 — —
SCHEMBL10072848 0.88 — —
SCHEMBL12049855 0.71 — —
SCHEMBL12769538 0.71 — —
SCHEMBL13900379 0.70 — —
SCHEMBL24487744 0.69 TSHR (0.32) —
SCHEMBL13146126 0.69 CA2 (0.33) —
SCHEMBL1038767 0.69 CA2 (0.33) —
SCHEMBL12049857 0.69 L3MBTL1 (0.31) —
SCHEMBL12769537 0.69 L3MBTL1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071567-B2 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication ROCHE PALO ALTO LLC (US) 2011-12-06 — — US disclosed
US-20100003213-A1 4'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION DEVOS RENE ROBERT 2010-01-07 — — US disclosed
Send feedback